MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Specialized palliative care for advanced Parkinsonian syndromes: bridging the gap

K. Cantu Flores, E. Mcrae, K. Waldmann, R. Kline, V. Bruno (Calgary, Canada)

Meeting: 2025 International Congress

Keywords: Interventions, Parkinson’s, Parkinsonism

Category: Palliative Care

Objective: The Advanced Care Team for Parkinson’s (ACT-PD) pilot program at the Calgary Movement Disorders Clinic aimed to bridge gaps in specialized palliative care for patients with advanced Parkinsonian syndromes through a structured, multidisciplinary approach.

Background: Over 100,000 Canadians live with Parkinson’s disease (PD) and related disorders, a number expected to double by 2030. Despite this, access to specialized neurological and palliative care remains limited, resulting in high symptom burden and fragmented care.

Method: ACT-PD provided quarterly multidisciplinary consultations with as-needed access, integrating movement disorder neurology, palliative care, social work, psychology, and spiritual care. Interventions included advance care planning, shared decision-making, symptom optimization, pain and mood management, caregiver support, and coordination with community resources and long-term care facilities. Outcomes were assessed every three months, capturing symptom burden, quality of life, caregiver strain, and healthcare utilization. Demographic and clinical characteristics were analyzed for subgroup differences.

Results: Among 113 patients (64.3% male, mean age 62.6 years, mean disease duration 10.6 years), 59.8% had PD, 17.5% Progressive Supranuclear Palsy (PSP), 14.4% Multiple System Atrophy, 5.2% Corticobasal Syndrome, and 3.1% Lewy Body Dementia. Overall, symptom burden decreased significantly with ESAS-PD scores decreased from 40.5 to 28.7, with men with PD showing a 19-point reduction and men with PSP (ages 65-80) improving by 22 points.  Caregiver burden (ZBI-12) declined from 25.83 to 20.23, and particularly Middle Eastern women (ages 61-75), showed the greatest improvement in quality of life (+9 points). 92% of participants engaged in advance care planning, leading to 58% modifying their goals of care. Among those who passed away, 70% had their preferred place of death honored.

Conclusion: ACT-PD improved symptom management, advance care planning, caregiver well-being, and healthcare utilization, while ensuring most patients received end-of-life care in their preferred setting. These findings support the need for expanded access to multidisciplinary palliative care in advanced Parkinsonian syndromes.

To cite this abstract in AMA style:

K. Cantu Flores, E. Mcrae, K. Waldmann, R. Kline, V. Bruno. Specialized palliative care for advanced Parkinsonian syndromes: bridging the gap [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/specialized-palliative-care-for-advanced-parkinsonian-syndromes-bridging-the-gap/. Accessed October 6, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/specialized-palliative-care-for-advanced-parkinsonian-syndromes-bridging-the-gap/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley